Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang Li(Hospital of Hebei Province), P. Charles Lin(Vanderbilt University), Yu Shyr(Vanderbilt University), Laura M. DeBusk(Vanderbilt University), Brenda Green‐Jarvis(Vanderbilt University), Koari Fukuda(Vanderbilt University), Lynn M. Matrisian(Pancreatic Cancer Action Network), Barbara Fingleton(Vanderbilt University), David P. Carbone(Vanderbilt University)
Cited by 1,135
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k